There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Ending the Diagnostic Odyssey Act of 2019

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to enable States to better provide access to whole genome sequencing clinical services for certain undiagnosed children under the Medicaid program, and for other purposes.


Actions Overview (1)

Date Actions Overview
12/19/2019Introduced in Senate

All Actions (1)

Date All Actions
12/19/2019Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211)
Action By: Senate

Cosponsors (4)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Jones, Doug [D-AL]* 12/19/2019
Sen. McSally, Martha [R-AZ]* 12/19/2019
Sen. Menendez, Robert [D-NJ]* 12/19/2019
Sen. Smith, Tina [D-MN] 03/05/2020

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Finance12/19/2019 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Latest Summary (1)

There is one summary for S.3116. View summaries

Shown Here:
Introduced in Senate (12/19/2019)

Ending the Diagnostic Odyssey Act of 2019

This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.

Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.

The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.